agilon health (NYSE:AGL) Shares Up 10.7% – Here’s Why

agilon health, inc. (NYSE:AGL)’s stock price shot up 10.7% during trading on Wednesday . The stock traded as high as $1.78 and last traded at $1.76. 542,032 shares were traded during mid-day trading, a decline of 89% from the average session volume of 4,938,274 shares. The stock had previously closed at $1.59.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on AGL shares. Evercore ISI cut their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Royal Bank of Canada reissued an “outperform” rating and set a $3.00 target price on shares of agilon health in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $6.05.

agilon health Stock Performance

The stock has a market capitalization of $688.07 million, a PE ratio of -1.87 and a beta of 0.60. The business’s fifty day moving average price is $2.97 and its 200-day moving average price is $4.81. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the firm earned ($0.06) EPS. As a group, equities research analysts expect that agilon health, inc. will post -0.47 EPS for the current year.

Insider Transactions at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after purchasing an additional 371,537 shares in the last quarter. Capital International Investors increased its holdings in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares during the period. State Street Corp raised its stake in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Finally, Citigroup Inc. grew its stake in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.